Skip to main content Skip to section navigation Skip to footer
Vivani Medical, Inc.
  • Investors
  • IR Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Our Company
    • Overview
    • Executive Leadership
    • Code of Ethics
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Annual Reports & Proxy Statements
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
    • Privacy

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
      Mar 24, 2025 8:30am EDT

      Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

      Mar 13, 2025 7:30am EDT

      Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

      Mar 12, 2025 8:30am EDT

      Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

      Dec 19, 2024 8:30am EST

      Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

      Dec 04, 2024 8:30am EST

      Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

      Nov 13, 2024 8:30am EST

      Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

      Oct 22, 2024 8:30am EDT

      Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

      Sep 26, 2024 8:30am EDT

      Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

      Sep 23, 2024 8:57am EDT

      Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

      Sep 04, 2024 8:00am EDT

      Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

      • Previous Pagearrow_back
      • Page 1
      • Page 2
      • Page 3
      • Page 4
      • Page 5
      • Page 6
      • Page 7
      • Page 8
      • Page 9
      • Page 10
      • …
      • Page 20
      • Next Pagearrow_forward
      rss_feed News RSS
      • Email Alerts
      • Contacts
      • RSS News Feed
      ©2025 Vivani Medical, Inc. All Rights Reserved.
      Privacy Policy Disclaimer Sitemap